← Back to Patent Explorer
US4315852A Expired / Lapsed US ⏱️ 0.0 years remaining

Extraction of interferon from bacteria

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1980-12-29
•
Granted: 1982-02-16
•
Expires: 2000-12-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of extracting leucocyte interferon from interferon-expressing bacterial cells comprising acidifying a suspension of interferon-containing bacterial cells, removing substantially all of the suspension liquid from the cells, preparing a second suspension of the acidified cells, neutralizing said second suspension, separating the interferon containing liquid from the suspended cells, and extracting the interferon from said liquid.

Inventors

  • 👤 Paul Leibowitz
  • 👤 Marvin J. Weinstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:49
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/555; C07K14/56; C12; C12N; C12N1/00; C12N1/005; Y; Y10; Y10S; Y10S435/00; Y10S435/811; Y10S530/00; Y10S530/82; Y10S530/825

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 56 words
A method of extracting leucocyte interferon from interferon-expressing bacterial cells comprising acidifying a suspension of interferon-containing bacterial cells, removing substantially all of the suspension liquid from the cells, preparing a second suspension of the acidified cells, neutralizing said second suspension, separating the interferon containing liquid from the suspended cells, and extracting the interferon from said liquid.
Claim 2
Independent Claim 56 words
A method of extracting leucocyte interferon from interferon-expressing bacterial cells comprising acidifying a suspension of interferon-containing bacterial cells, removing substantially all of the suspension liquid from the cells, preparing a second suspension of the acidified cells, neutralizing said second suspension, separating the interferon containing liquid from the suspended cells, and extracting the interferon from said liquid.
Claim 3
Dependent Claim 17 words
A method according to claim 1, wherein said suspension is acidified with sulfuric acid or phosphoric acid.
Claim 4
Dependent Claim 19 words
A method according to claim 1, wherein said suspension is acidified to a pH of about 1.3 to 4.0.
Claim 5
Dependent Claim 19 words
A method according to claim 1, wherein said suspension is acidified to a pH of about 2.0 to 2.5.
Claim 6
Dependent Claim 18 words
A method according to claim 1, wherein said second suspension is neutralized with potassium hydroxide or sodium hydroxide.
Claim 7
Dependent Claim 20 words
A method according to claim 1, wherein said second suspension is neutralized to a pH of about 7.0 to 8.0.
Claim 8
Dependent Claim 20 words
A method according to claim 1, wherein said second suspension is neutralized to a pH of about 7.2 to 7.6.
Claim 9
Dependent Claim 12 words
A method according to claim 1, wherein said bacteria is E. coli.

References Cited (Backward Citations)

US3699222A Cited
US3265581A Cited
US3414651A Cited
US3256152A Cited
US4266024A Cited
GB2037296A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-02-15 1985-08-17 1986-02-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-02-15 1989-08-17 1990-02-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-02-15 1993-08-17 1994-02-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag